Compass Pathways has reported that its second pivotal Phase 3 [...]

This is a disease awareness paid article sponsored by Sanofi. [...]

Alto Neuroscience has received FDA Fast Track designation for its [...]

Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium [...]

New approach targets Elk1 to restore neuroplasticity without sedation or [...]

As psychedelic-assisted therapies move closer to mainstream psychiatric care, Cybin, [...]

A new music initiative is raising awareness of autoimmune Type [...]